ESR1 and breast carcinoma: A study has demonstrated that DNA hypermethylation occurs predominantly at the estrogen-responsive enhancers and is associated with reduced ESR1 binding and decreased expression of crucial ERα activity regulators, thereby abating endocrine responses in ERα-positive breast cancers [22].